Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 8529 - 8536 of 12011 results
CMS Notifies States of AMP Rule Requirements: 340B Providers Should Take Note
February 16, 2016| Blog| Viewpoint
Federal Circuit Declines to Disturb Established Precedent Regarding the Exhaustion of Patent Rights
February 16, 2016| Blog| Viewpoint
A Preview of Business Immigration in 2016: Proposed Immigrant Visa Reforms (Part 3/6)
February 16, 2016| Blog| Viewpoint
Top Ten Reasons Why US Trademark Searches are Important to Every Business
February 15, 2016| Article| Viewpoint
MintzTech Connect Industry News - February 2016
February 15, 2016| Article| Viewpoint
MintzTech Leaders in the News - 2016 MIT 100K Entrepreneurship Competition
February 15, 2016| Article| Viewpoint
MintzTech Innovator Profile - Conduce
February 15, 2016| Article| Viewpoint
Looking Above and Beyond: The Evolving UAS and Drone Regulations
February 15, 2016| Article| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|